C&

CNS & Neurological Disorders - Drug Targets

CNS & Neurological Disorders - Drug Targets is a journal focused on CNS and neurological disorders and drug targets. It publishes themed issues and is indexed in Scopus, SCI Expanded, and MEDLINE/PubMed. The journal lists an Impact Factor of 3 and states that open access articles are also available on ScienceDirect.

Looking to publish in CNS & Neurological Disorders - Drug Targets? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.

Existing customer login
Subject Neurosciences, Pharmacology & Pharmacy
Impact Factor 3
Quartile Q2
Open Access Type Open
ISSN 1871-5273
eISSN 1996-3181
Invitation Only No
Cost Range Publication is supported by an Article Processing Charge (APC).

Submission Instructions

CNS & Neurological Disorders - Drug Targets accepts the following article types. Click on an article type to view submission instructions.

Review Articles

Cover Letter A signed copyright letter must be submitted with the manuscript by the corresponding author on behalf of all co-authors. The copyright letter must confirm that all co-authors approve the submission.
Abstract A structured abstract is required for Review Articles. The abstract must not exceed 250 words. The abstract must be structured with explicit bold inline or run-in subheadings.
Manuscript Review Articles must be 6000–10000 words excluding figures, structures, photographs, schemes, and tables. Review Articles must be organized into Title, Title Page, Structured Abstract, Graphical Abstract, Keywords, Text Organization, Conclusion, List of Abbreviations, Availability of Data and Materials, Funding, Conflict of Interest, Acknowledgements, References, Appendices, Figures or Illustrations, Chemical Structures, Tables, and Supportive or Supplementary Material. The manuscript must include a graphical abstract, 6 to 8 keywords, a list of abbreviations, a conflict of interest statement, acknowledgements, and a declaration of any significant use of AI tools.
References Review Articles must contain at least 100 references. References should be submitted preferably in ACS, IEEE, or Vancouver style. References must be cited in the text with square-bracketed numbers and the bibliography must be complete and fully formatted before submission.
Figures & Tables There is no restriction on the number of figures, tables, or additional files that can be included online. Figures and tables must be embedded in the manuscript text at the appropriate places, while figures must also be uploaded as separate files. Each figure must contain a single illustration with a caption, and tables must be submitted in Microsoft Word table format with a self-explanatory title or caption.
Reformat to CNS & Neurological Disorders - Drug Targets using Livewrite Premium

Mini-Reviews

Cover Letter A signed copyright letter must be submitted by the corresponding author on behalf of all co-authors.
Abstract Abstract must not exceed 250 words. Abstract must use explicit bold inline or run-in subheadings.
Manuscript Mini-Reviews must be 3000-6000 words excluding figures, structures, photographs, schemes, and tables. Manuscript must be divided into title page, abstract, and main text. Manuscript must include 6 to 8 keywords, a conflict of interest statement, an authors' contribution paragraph, a summary disclosure statement before the references, an Availability of Data and Materials section, and disclosure of any significant AI use.
References Mini-Reviews must contain 75 or more references. References should be submitted preferably in ACS, IEEE, or Vancouver style. References must be numbered in square brackets in the text, be complete and accurate, include access dates for online citations, and exclude abstracts, unpublished data, and personal communications from the reference list.
Figures & Tables There is no restriction on the number of figures, tables, or additional files that can be included online. Figures and tables must be embedded in the manuscript text at their appropriate placements, although figure files must also be uploaded separately for online submission. Figures must be numbered consecutively with captions and each table must be numbered in Arabic numerals and include a self-explanatory title or caption.
Reformat to CNS & Neurological Disorders - Drug Targets using Livewrite Premium

Systematic Reviews

Cover Letter A signed copyright letter from the corresponding author is required with the submission.
Abstract A structured abstract is required. Abstract must not exceed 250 words. Abstract must be structured. Abstract must use explicit subheadings presented as inline or run-in headings in bold, and a registered systematic review must include the registration number as the last line.
Manuscript Manuscript must be 4000-6000 words, excluding figures, structures, photographs, schemes, and tables. Manuscript must include title page, abstract, and main text, and systematic reviews must address the methods used for selecting, locating, extracting, and synthesizing data. Manuscript must include 6 to 8 keywords, a conflict of interest statement, funding information, an Authors' Contribution paragraph, a CRediT Author Statement, a list of abbreviations if abbreviations are used at least three times, and disclosure of significant AI use.
References Systematic reviews must contain 100 or more references. References should be submitted preferably in ACS, IEEE, or Vancouver style. References must be cited in the text using square-bracketed numbers and the bibliography must be complete, accurate, and fully formatted before submission.
Figures & Tables There is no restriction on the number of figures, tables, or additional files that can be included online. Figures and tables must be embedded in the manuscript text according to their appropriate placement, although figures must also be uploaded as separate files. Each figure must include only a single illustration with a legend or caption, and each table must include a self-explanatory title or caption.
Reformat to CNS & Neurological Disorders - Drug Targets using Livewrite Premium

Meta-Analyses

Cover Letter A signed copyright letter must be submitted with the manuscript by the corresponding author on behalf of all co-authors.
Abstract A structured abstract is required. Abstract must not exceed 250 words. Abstract must be structured.
Manuscript Manuscript must be divided into title page, abstract, and main text. The manuscript must include 6 to 8 keywords, a conflict of interest statement, an authors' contribution paragraph, a CRediT Author Statement, and disclosure of significant AI tool use.
References References should be submitted preferably in ACS, IEEE, or Vancouver style. References must be cited in the text with numbers in square brackets and the bibliography must be complete and fully formatted before submission.
Figures & Tables There is no restriction on the number of figures, tables, or additional files that can be included online. Illustrations and tables must be embedded in the manuscript text according to their appropriate placement, although figures and illustrations must also be uploaded as separate files for online submission. Each figure must be numbered consecutively, include a legend or caption, contain only a single illustration with multipart figures combined into one composite file, and each table must be submitted in Microsoft Word table format with a self-explanatory caption.
Reformat to CNS & Neurological Disorders - Drug Targets using Livewrite Premium

Research Articles

Cover Letter A signed copyright letter must be submitted by the corresponding author on behalf of all co-authors.
Abstract A structured abstract is required for Research Articles. Abstract must not exceed 250 words. The abstract must be structured. The abstract must use explicit subheadings presented as inline or run-in headings in bold.
Manuscript Research Articles must be 4000–6000 words excluding figures, structures, photographs, schemes, and tables. Research Articles must begin with the title page and abstract and be structured into Introduction, Materials and Methods, Results, Discussion, Conclusion, Conflict of Interest, Acknowledgements, and References. The manuscript must include a graphical abstract, 6 to 8 keywords, a list of abbreviations, and declarations for consent for publication and conflict of interest.
References Research Articles must contain at least 75 references. References should be submitted in ACS or Vancouver style. References must be cited in the text with numbers in square brackets and provided exactly in the journal's specific format.
Figures & Tables There is no restriction on the number of figures, tables, or additional files that can be included with each article online. Figures and tables must be embedded in the manuscript text according to their appropriate placement, and figures must also be uploaded as separate files. Figures must be numbered consecutively with captions, and tables must be numbered in Arabic numerals and include a self-explanatory title or caption.
Reformat to CNS & Neurological Disorders - Drug Targets using Livewrite Premium

Randomized Drug Clinical Trial Studies

Cover Letter A signed copyright letter must be submitted by the corresponding author on behalf of all co-authors.
Abstract An abstract is required. Abstract must not exceed 250 words. Abstract must use explicit subheadings presented as inline or run-in headings in bold. The abstract must include the trial registry name, registration identification number, and registry URL at the end of the abstract.
Manuscript Manuscript must be 4000-6000 words excluding figures, structures, photographs, schemes, and tables. Manuscript must clearly state an objective or hypothesis and include design and methods, study setting and dates, participants with inclusion and exclusion criteria or data sources and selection methods, essential features of interventions, main outcome measures, main results, a comment section addressing context and limitations, conclusions, and a "Randomization and Masking" section within Methods. Manuscript must include 6 to 8 keywords, a conflict of interest statement, an Authors' Contribution paragraph, a CRediT Author Statement, funding information, acknowledgements if applicable, and disclosure of any significant use of AI tools.
References Manuscript must include 50 or more references. References should be submitted preferably in ACS, IEEE, or Vancouver style. References must be cited in the text with numbers in square brackets and the bibliography must be complete and fully formatted before submission.
Figures & Tables There is no restriction on the number of figures, tables, or additional files that can be included online. Figures and tables must be embedded in the manuscript text according to their appropriate placement, although figure files must also be uploaded separately for online submission. Each figure must contain a single illustration with a legend or caption, and each table must be created in Microsoft Word table format with a self-explanatory title or caption.
Reformat to CNS & Neurological Disorders - Drug Targets using Livewrite Premium

Short Communications

Cover Letter A signed copyright letter must be submitted with the manuscript by the corresponding author on behalf of all co-authors. The copyright letter must be signed by all contributing authors, who take full responsibility for the manuscript contents.
Abstract An abstract is required. Abstract must not exceed 250 words. Abstract must be structured with explicit inline or run-in bold subheadings.
Manuscript Short Communications must be 2000-3000 words, excluding figures, structures, photographs, schemes, and tables. Manuscript must be divided into title page, abstract, and main text. The manuscript must include 6 to 8 keywords, a conflict of interest statement, an Authors' Contribution paragraph, a CRediT Author Statement, funding information, an Availability of Data and Materials section, and disclosure of any significant AI use.
References Short Communications must contain 25 or more references. References should be submitted preferably in ACS, IEEE, or Vancouver style. References must be cited in the text with numbers in square brackets and listed as complete and accurate entries in the bibliography.
Figures & Tables There is no restriction on the number of figures, tables, or additional files that can be included with each article online. Figures and tables must be embedded in the manuscript text, while figure files must also be uploaded separately for online submission. Each figure must contain a single illustration with a legend or caption, and each table must include a self-explanatory title or caption.
Reformat to CNS & Neurological Disorders - Drug Targets using Livewrite Premium

Letters

Cover Letter A signed copyright letter must be submitted with the manuscript by the corresponding author on behalf of all co-authors.
Abstract Abstract must not exceed 250 words. Abstract must use explicit bold inline or run-in subheadings.
Manuscript Letters must be 3000-4000 words, excluding figures, structures, photographs, schemes, and tables. Manuscript must be divided into title page, abstract, and main text. Manuscript must include 6 to 8 keywords, a conflict of interest statement, an authors' contribution paragraph, and disclosure of any significant use of AI tools.
References Letters must contain 40 or more references. References should be submitted preferably in ACS, IEEE, or Vancouver style. References must be cited in the text with numbers in square brackets and the bibliography must be complete, accurate, and fully formatted before submission.
Figures & Tables There is no restriction on the number of figures and tables that can be included online. Figures and tables must be embedded in the manuscript text according to their appropriate placement, although figures and illustrations must also be uploaded as separate files for online submission. Each figure must include only a single illustration and each table must include a self-explanatory title or caption.
Reformat to CNS & Neurological Disorders - Drug Targets using Livewrite Premium

Case Reports

Cover Letter A signed copyright letter must be submitted with the manuscript. For case reports involving individual data, the copyright letter must include a declaration of approval and consent-to-disclose.
Abstract An abstract is required. Abstract must not exceed 250 words. Abstract must use explicit subheadings presented as inline or run-in headings in bold.
Manuscript Case Reports must be 1500–2500 words, excluding figures, structures, photographs, schemes, and tables. Manuscript must be divided into title page, abstract, and main text. Manuscript must include 6 to 8 keywords, a graphical abstract, a conflict of interest statement, an Authors' Contribution paragraph, a CRediT Author Statement, and for case reports involving individual data a stand-alone declaration of approval and consent-to-disclose at the end of the article.
References Case Reports must contain 40 or more references. References should be submitted preferably in ACS, IEEE, or Vancouver style. References must be cited in the text using square-bracketed numbers and listed as complete and accurate entries, with online citations including the date of access and abstracts, unpublished data, and personal communications excluded from the reference list.
Figures & Tables There is no restriction on the number of figures or tables that can be included online. Figures and tables must be embedded in the manuscript text at their appropriate placement, although figures and illustrations must also be uploaded as separate files for online submission. Figures must be numbered consecutively with legends provided, and tables must be numbered in Arabic numerals sequentially and include a self-explanatory title or caption.
Reformat to CNS & Neurological Disorders - Drug Targets using Livewrite Premium

Recent Publications

Myelin and Oligodendrocyte Dysfunction in Demyelinating and Neurodegenerative Disorders: Signaling Pathways and Therapeutic Targets

Shivang Shukla, Vivek Srivastava, Harshita Gaur, Anjali Rai

10.2174/0118715273437393260729093129
View Publication

An Innovative Strategy for Treating Neurodegenerative Disorders through Exosome-based Smart Delivery Systems: A Comprehensive Review

MD. Abubakar, Ritu Dahiya, Lokesh Nama, Kanika Goyal, Abhishek Ambawatiya, Mamta Bishnoi, Amita Rai, Krishna Murti, Nitesh Kumar

10.2174/0118715273453626260724060812
View Publication

From Molecules to Minds: Redefining the Power of Psychedelics and Entactogens in Treating Brain Disorders

Sampriti Paul, Sonal Dubey, Mayur Yergeri Chandrasekharappa, Prashant Tiwari

10.2174/0118715273452468260729080541
View Publication

The Multifaceted Role of the P2X7 Receptor in Alzheimer’s Disease: A Unifying Pathological Link

Tejaswini Reddy Jeeru, Nagarjuna Palathoti, Gomathi Swaminathan

10.2174/0118715273460900260724035926
View Publication

WNT Signaling in Alzheimer’s Disease: Mechanisms, Pathological Implications, and Therapeutic Potential

Dileep Kumar, Astik Manju Ashesh, Sanjana Gupta, Ajay Kumar, Sathiyanarayanan Lohidasan, Tahereh Jamshidnejad Tosaramandani

10.2174/0118715273455895260722103746
View Publication

Frequently asked questions

How long does it take to publish?

Quick Track allows online publication within 2 weeks of receipt of final approved galley proofs. Total publication time from first receipt of the manuscript to online publication is 10 weeks under Quick Track, subject to acceptance and author revision within one week. Revised papers are usually requested within 15 days, and the time frame for revision may vary from one to four weeks.

Reformat to CNS & Neurological Disorders - Drug Targets using Livewrite Premium

Is a cover letter required?

A signed copyright letter must be submitted with the manuscript by the corresponding author on behalf of all co-authors.

Reformat to CNS & Neurological Disorders - Drug Targets using Livewrite Premium

What are the publication costs?

Publication is supported by an Article Processing Charge (APC).

Reformat to CNS & Neurological Disorders - Drug Targets using Livewrite Premium

Research Topics

Alzheimer's disease research and treatments Tryptophan and brain disorders Cholinesterase and Neurodegenerative Diseases Neuroinflammation and Neurodegeneration Mechanisms Parkinson's Disease Mechanisms and Treatments Neuroscience and Neuropharmacology Research Diverse Scientific and Economic Studies 14-3-3 protein interactions Neurological Disorders and Treatments Neurological Disease Mechanisms and Treatments Nerve injury and regeneration Nuclear Receptors and Signaling Neurotransmitter Receptor Influence on Behavior Computational Drug Discovery Methods Neurogenesis and neuroplasticity mechanisms Cancer Mechanisms and Therapy Cannabis and Cannabinoid Research Stress Responses and Cortisol Treatment of Major Depression Nicotinic Acetylcholine Receptors Study Medicinal Plants and Neuroprotection Genetic Neurodegenerative Diseases Neuropeptides and Animal Physiology Mitochondrial Function and Pathology Neurological disorders and treatments

Related Journals

EJ
European Journal of Pharmaceutics and Biopharmaceutics Elsevier BV
IJ
International Journal of Nanomedicine Dove Medical Press
LS
Life Sciences Elsevier BV
AI
Advances in Therapy Adis, Springer Healthcare
NR
Nature reviews. Neuroscience NATURE PORTFOLIO
FI
Frontiers in Neuroscience Frontiers Media